Alpha IVF Group Bhd group managing director Datuk Dr Colin Lee Soon Soo. —LOW LAY PHON/The Star
PETALING JAYA: Alpha IVF Group Bhd remains committed to its growth strategy, focusing on both domestic and international expansion.
In a statement, the fertility care specialist said that domestically, it is progressing with its fourth upcoming specialist centre, the Alhaya Fertility Centre in Kuala Lumpur (Alhaya-KL).
“The new centre is aimed at attracting more Muslim patients locally and internationally, as Alhaya-KL will be positioned as a Muslim-friendly centre.”
The centre, upon receiving approval from the Ministry Of Health, commenced operations on April 8, 2024.
Aside from that, the Group is actively working on setting up a specialist centre in Bali as part of its broader regional expansion strategy.
“Last year, Alpha IVF Group entered into an agreement with PT Hotel Indonesia Natour to reserve the leasing of a plot of land with a total land area of approximately 6,000 sq metres in the Health and Tourism Special Economic Zone in Bali, Indonesia.
Both parties have commenced negotiations on the terms and conditions of the definitive agreement.
The specialist centre in Bali will be another overseas centre for Alpha IVF Group following the successful setting up of the Singapore centre in November 2019.
Alpha IVF posted a net profit attributable to shareholders (patmi) of RM38.9mil on revenue of RM120.8mil for the nine months ended Feb 29, 2024 (9M24).
There is no comparative quarter as the company was listed on the ACE market of Bursa Malaysia last month.
In the previous financial year ended May 31, 2023, the group recorded RM137.5mil revenue and RM53.2mil patmi.
In the same statement, Alpha IVF group managing director Datuk Dr Colin Lee Soon Soo said he remains optimistic about the group’s prospects and ability to sustain growth, especially with the upward trajectory of patients choosing Malaysia for reproductive treatments.
“To this end, we will leverage on our expertise, cutting-edge technology and in-house system of systems to meet the evolving needs of patients seeking reproductive treatment and continue our aspirations of empowering individuals and couples on their path to parenthood.”
